摘要
相较于体外膜肺氧合,体外循环二氧化碳清除(ECCO_(2)R)能有效清除体内潴留CO_(2),治疗风险及并发症低,具有相对低创、低技术门槛及低成本的优势。但目前仍有较多研究发现ECCO_(2)R的临床应用存在一定问题,主要包括适用人群及抗凝问题等,限制其临床推广。本文拟对ECCO_(2)R技术的临床应用最新进展作一简述。
Extracorporeal CO_(2)removal(ECCO_(2)R)is an effective treatment for removing CO_(2)in circulation.With lower risk and complications,ECCO_(2)R has the advantages of lower invasiveness,technical requirements and cost compared with extracorporeal membrane oxygenation(ECMO).However,some studies have found that there are problems in the clinical application of ECCO_(2)R,mainly including the applicable population and anticoagulant problems,which limit its clinical promotion.This article aims to review the recent progression of clinical application of ECCO_(2)R technology.
作者
胡臻(综述)
龚德华(审校)
HU Zhen;GONG Dehua(National Clinical Research Center of Kidney Diseases,Jinling Hospital,Nanjing University School of Medicine,Nanjing 210016,China)
出处
《肾脏病与透析肾移植杂志》
CAS
CSCD
北大核心
2022年第5期475-479,共5页
Chinese Journal of Nephrology,Dialysis & Transplantation
基金
国家重点研发计划课题(2017YFC1104404)
江苏省临床医学研究中心项目(YXZXA2016003)。
关键词
体外循环二氧化碳清除
临床应用
extracorporeal CO_(2) removal
clinical application